RxDoctor Payments DataLook up a doctor →

Farzaneh Farzin, MD

Radiation Oncology · Las Vegas, NVNPI 1154339778

Payments from drug & device makers

$12,344in general payments, 2019–2025

Across 373 payments — averaging $33.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$4K
  • Daiichi Sankyo Inc.$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Novartis$976
  • Exelixis Inc.$445
  • Incyte Corporation$427
  • plus $4K from 45 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca15$3,743
Daiichi Sankyo Inc.138$1,307
Regeneron Healthcare Solutions, Inc.20$1,052
Novartis38$976
Exelixis Inc.16$445
Incyte Corporation5$427
Sobi, Inc16$350
Progenics Pharmaceuticals, Inc.3$320
Merck10$251
Hologic Inc1$211
Amgen7$208
Visionrt, Inc.1$199
Beigene USA, Inc.8$197
Johnson & Johnson11$189
AbbVie2$167
Servier Pharmaceuticals LLC7$151
Regeneron1$149
Galderma Laboratories, L.p.1$142
UCB, Inc.1$125
Bayer7$125
Novo Nordisk1$125
Icotec Medical Inc.1$124
Genentech USA, Inc.7$112
Sanofi5$110
Novocure Inc.2$110
Geron Corporation4$107
Karyopharm Therapeutics Inc.3$95
EMD Serono, Inc.5$88
Sumitomo Pharma America, Inc.4$75
Coherus Oncology, Inc.3$69
Beone Medicines USA, Inc.2$53
Stemline Therapeutics Inc.3$50
Bristol Myers Squibb3$47
Dendreon Pharmaceuticals LLC2$45
Takeda Pharmaceuticals U.S.A., Inc.2$43
GSK2$41
Seagen Inc.2$37
Lilly USA, LLC1$26
Reflexion Medical, Inc.1$25
Array Biopharma Inc1$23
Sun Pharmaceutical Industries Inc.1$23
Mirati Therapeutics, Inc.1$22
Agios Pharmaceuticals, Inc.1$22
Genmab U.S., Inc.1$22
Sirtex Medical Inc1$18
Puma Biotechnology, Inc.1$18
Eisai Inc.1$18
Astellas Pharma US Inc1$18
Pfizer1$17
Forte Bio-pharma LLC1$15
Taiho Oncology, Inc.1$13

How this compares

$12,344 in reported general payments places this provider in the 85th percentile of 47 radiation oncology providers in Nevada.

See all radiation oncology providers in Nevada →

Medicare billing

Part B allowed, 2024
$1,258,265
Medicare patients
150
Services billed
5,946

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →